Evoke Pharma Total Current Liabilities 2012-2024 | EVOK
Evoke Pharma total current liabilities from 2012 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Evoke Pharma Annual Total Current Liabilities
(Millions of US $) |
| 2023 |
$3 |
| 2022 |
$2 |
| 2021 |
$1 |
| 2020 |
$8 |
| 2019 |
$2 |
| 2018 |
$2 |
| 2017 |
$2 |
| 2016 |
$1 |
| 2015 |
$2 |
| 2014 |
$2 |
| 2013 |
$2 |
| 2012 |
$1 |
| 2011 |
$0 |
Evoke Pharma Quarterly Total Current Liabilities
(Millions of US $) |
| 2024-09-30 |
$10 |
| 2024-06-30 |
$9 |
| 2024-03-31 |
$9 |
| 2023-12-31 |
$10 |
| 2023-09-30 |
$2 |
| 2023-06-30 |
$2 |
| 2023-03-31 |
$2 |
| 2022-12-31 |
$2 |
| 2022-09-30 |
$2 |
| 2022-06-30 |
$1 |
| 2022-03-31 |
$1 |
| 2021-12-31 |
$1 |
| 2021-09-30 |
$1 |
| 2021-06-30 |
$6 |
| 2021-03-31 |
$6 |
| 2020-12-31 |
$8 |
| 2020-09-30 |
$7 |
| 2020-06-30 |
$7 |
| 2020-03-31 |
$2 |
| 2019-12-31 |
$2 |
| 2019-09-30 |
$2 |
| 2019-06-30 |
$1 |
| 2019-03-31 |
$1 |
| 2018-12-31 |
$2 |
| 2018-09-30 |
$2 |
| 2018-06-30 |
$1 |
| 2018-03-31 |
$1 |
| 2017-12-31 |
$2 |
| 2017-09-30 |
$3 |
| 2017-06-30 |
$2 |
| 2017-03-31 |
$1 |
| 2016-12-31 |
$1 |
| 2016-09-30 |
$1 |
| 2016-06-30 |
$6 |
| 2016-03-31 |
$2 |
| 2015-12-31 |
$2 |
| 2015-09-30 |
$2 |
| 2015-06-30 |
$3 |
| 2015-03-31 |
$3 |
| 2014-12-31 |
$2 |
| 2014-09-30 |
$2 |
| 2014-06-30 |
$2 |
| 2014-03-31 |
$3 |
| 2013-12-31 |
$2 |
| 2013-09-30 |
$3 |
| 2013-06-30 |
$2 |
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2011-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.007B |
$0.005B |
|
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
|
